DOI: https://doi.org/10.26641/2307-0404.2018.2(part1).129514

Possible predictors of depressive syndrome in patients with chronic obstructive pulmonary disease.

T. O. Pertseva, L. I. Konopkina, Yu. V. Guba

Abstract


Recently, the problem of depressive syndrome in COPD patients often attracts the attention of doctors and scientists. It is important to study the relationship between the presence of the depressive syndrome, on the one hand, and the clinical and functional characteristics of COPD patients on the other, in order to determine the categories of patients inclined to develop a depressive syndrome. The purpose of the study: to determine the relationship between the presence of depressive syndrome in COPD patients with the severity of their clinical symptoms of COPD and the level of functional impairments. 52 COPD patients of clinical groups C and D were examined. Depending on the presence of depressive syndrome patients were divided into two subgroups: a subgroup 1 – 15 COPD patients with concomitant depressive syndrome, a subgroup 2 – 37 people without it. The examination included general clinical and functional methods. It was determined that the development of depressive syndrome in COPD patients can be affected by the high severity of clinical symptoms of COPD in general, decreased tolerance to physical activity, long duration of the disease, poor quality of life. At the same time, the levels of functional indicators, in particular, OFV1 and SpO2, may not have a significant relationship with the occurrence of depressive syndrome, even in patients with severe COPD.


Keywords


chronic obstructive pulmonary disease; depressive syndrome; clinical symptoms; functional parameters

References


Gavrisyuk VK, Yachnik AI, Berenda EA. [Ana­lysis of the prospects for the use of functional tests with walking in patients with chronic lung diseases]. Uk­rainskyi pulmonolohichnyi zhurnal. – 2004;3:46-50. Russian.

[On approving and implementation of medical-technological documents on standardization of medical assistance in the case of chronic obstructive pulmonary disease: Order of the Ministry of Health ofUkrainedated June 27, 2013 N 555]. Кyiv. 2013;146. Ukrainian.

[On approval and implementation of medical-technological documents on standardization of medical care in case of depression: Order of the Ministry of Health ofUkrainedated December 25, 2014 N 1003]. Kyiv. 2014;60. Ukrainian.

Rebrova OJu. [Statistical analysis of medical data. Application of the STATISTICA software package]. Me­diasfera. 2002;312. Russian.

Cleland JA, et al. Associations of depression and anxiety with gender, age, health-related quality of life and symptoms in primary care COPD patients. Family practice. 2007;24:217-23.

Molen T, et al. Development, validity and respon­siveness of the Clinical COPD Questionnaire.Health and Quality of Life Outcomes. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC156640/

pdf/1477-7525-1-13.pdf.

Garvey C. Depression in patients with chronic obstructive pulmonary disease. Postgraduate Medical Journal. 2012;124:101-9.

Global initiative for chronic obstructive lung di­sease (GOLD). Global strategy for diagnosis, mana­gement, and prevention of chronic obstructive pulmonary disease. Update 2016. Available from: http://www.gold­copd.org/uploads/users/files/WatermarkedGlobal%20Strategy%202016(1).pdf

Ferrer M,Villasante C, Alonso J, Sobradillo V, et al. Interpretation of quality of life scores from theSt George’sRespiratory Questionnaire.European Respira­tory Journal. 2002;19:405-13.

Jones PW. Depression in Chronic Obstructive Pulmonary Disease. A Common Concomitant Disease. American Journal Respiratory Critical Care Medicine. 2011;183:562-3.

Julian LJ. Measures of Anxiety State-Trait An­xiety Inventory (STAI), Beck Anxiety Inventory (BAI), and Hospital Anxiety and Depression Scale-Anxiety (HADS-A). Arthritis Care & Research. 2011;63:467-72.

Putman-Casdorph, H,McCrone S. Chronic obs­tructive pulmonary disease, anxiety, and depression: state of the science. Heart Lung. 2009;38:34-47.

Iguchi A, et al. Relationship between depression in patients with COPD and the percent of predicted FEV1, BODE Index, and Health-Related Quality of Life. Res­piratory care. 2013;58:334-9.

Dowson C, et al. The use of the hospital anxiety and depression scale (HADS) in patients with chronic obstructive pulmonary disease: a pilot study.New Zea­landmedical journal. 2001;114:447-9.

Yohannes AM. Depression and COPD in older people: a review and discussion. British Journal of Com­munity Nursing. 2005;10:42-46.


GOST Style Citations


  1. Гаврисюк В.К. Анализ перспектив применения функциональних тестов с ходьбой у больных хро­ническими заболеваниями легких / В.К. Гаврисюк, А.И. Ячник, Е.А. Беренда // Укр. пульмонол. журнал. – 2004. – № 3. – С. 46-50.
  2. Про затвердження та впровадження медико-технологічних документів зі стандартизації медичної допомоги при хронічному обструктивному за­хворю­ванні легень: Наказ МОЗ України від 27.06.2013 р. № 555. – Київ, 2013. – 146 с.
  3. Про затвердження та впровадження медико-технологічних документів зі стандартизації медичної допомоги при депресії: Наказ МОЗ України від 25.12.2014 № 1003. – Київ, 2014. – 60 с.
  4. Реброва О.Ю. Статистический анализ меди­цинских данных. Применение пакета прикладных программ STATISTICA / О.Ю. Реброва – Москва: Медиасфера, 2002. – 312 с.
  5. Associations of depression and anxiety with gen­der, age, health-related quality of life and symptoms in primary care COPD patients / J.A. Cleland [et al.] // Family practice. – 2007. – Vol. 24. – P. 217–223.
  6. Development, validity and responsiveness of the Clinical COPD Questionnaire [Електронний ресурс] / T. Molen [et al.] / Healthand Quality of Life Outcomes. Режим доступу: http://www.ncbi.nlm.nih.gov/pmc/artic­les/PMC156640/pdf/1477-7525-1-13.pdf.
  7. Garvey C. Depression in patients with chronic ob­structive pulmonary disease / C. Garvey // Postgraduate Medical J. – 2012. – Vol. 124. – P. 101-109.
  8. Global initiative for chronic obstructive lung disease (GOLD). Global strategy for diagnosis, management, and prevention of chronic obstructive pulmonary disease. Update 2016. [Електронний ресурс]. – Режим доступу: http://www.goldcopd.org/uploads/­users/­files/WatermarkedGlobal%20Strategy%202016(1).pdf.
  9. Ferrer M. Interpretation of quality of life scores from the St George’s Respiratory Questionnaire / M. Ferrer, C. Villasante, J. Alonso, V. Sobradillo [et al.] // Eur. Resp. J. – 2002. – Vol. 19. – P. 405-413.
  10. Jones P.W. Depression in Chronic Obstructive Pul­monary Disease. ACommon Concomitant Disease / P.W. Jones // Am. J. Resp. Crit. Care Med. – 2011. – Vol. 183. – P. 562-563.
  11. Julian L.J. Measures of Anxiety State-Trait An­xiety Inventory (STAI), Beck Anxiety Inventory (BAI), and Hospital Anxiety and Depression Scale-Anxiety (HADS-A) / L.J. Julian // Arthritis Care&Research. – 2011. – Vol. 63, N S11. – P. 467-472.
  12. Putman-Casdorph H. Chronic obstructive pulmo­nary disease, anxiety, and depression: state of the science / H. Putman-Casdorph, S. McCrone // Heart. Lung. – 2009. – Vol. 38. – P. 34-47.
  13. Relation ship between depression in patients with COPD and the percent of predicted FEV1, BODE Index, and Health-Related Quality of Life / A. Iguchi [et al.] // Resp. Care. – 2013. – Vol. 58, N 2. – P. 334-339.
  14. The use of the hospital anxiety and depression scale (HADS) in patients with chronic obstructive pul­monary disease: a pilot study / C. Dowson [et al.] // New Zealand Medical J. – 2001. – Vol. 114. – P. 447-449.
  15. Yohannes A.M. Depression and COPD in older people: a review and discussion / A.M. Yohannes // Br. J. Community Nursing. – 2005. – Vol. 10. – P. 42-46.